CB2 cannabinoid receptors: Molecular, signaling, and trafficking properties

Cannabinoids and the Brain

Volumn , Issue , 2008, Pages 75-90

  Prather, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856787902     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-74349-3_6     Document Type: Chapter

References (90)

1. Alves ID, Salamon Z, Varga E, Yamamura HI, Tollin G, Hruby VJ (2003) Direct observation of G protein binding to the human delta-opioid receptor using plasmon-waveguide resonance spectroscopy. J Biol Chem 278:48890-48897.
2. Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z (1995) The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling. FEBS Lett 375:143-147.
3. Becher B, Antel JP (1996) Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18:1-10.
4. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaqueassociated glia in Alzheimer's disease brains. J Neurosci 23:11136-11141.
5. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Effector pathwaydependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonistdirected trafficking of receptor stimulus. Mol Pharm 54:94-104.
6. Bonhaus DW, Chang LK, Kwan J, Martin GR (1998) Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J Pharmacol Exp Ther 287:884-888.
7. Borner C, Hollt V, Kraus J (2006) Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells. Mol Pharm 69:1486-1491.
8. Borner C, Hollt V, Sebald W, Kraus J (2007) Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J Leukoc Biol 81:336-343.
9. 1. Biochem J 312:637-641.
10. 2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704-711.
11. 2: Implication for intracellular signalization cross-regulation. Mol Pharm 55:473-480.
12. 2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J Biol Chem 274:20397-20405.
13. 1 cannabinoid receptor signalling in Parkinson's disease. Curr Opin Pharmacol 3:54-61.
14. 2 cannabinoid receptor. Biochim Biophys Acta 1576:255-264.
15. 3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305.
16. 2 receptor-dependent mechanism. Mol Pharm 65:999-1007.
17. Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 74:1317-1324.
18. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G (2002) Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 135:181-187.
19. Cravatt B, Lichtman A (2004) The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol 61:149-160.
20. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharm 48:443-450.
21. 1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284:291-297.
22. Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P (1997) Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guineapig trachea. Br J Pharmacol 121:773-781.
23. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
24. Galve-Roperh I, Sanchez C, Cortes ML, del Pulgar TG, Izquierdo M, Guzman M (2000) Antitumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313-319.
25. Gerard CM, Mollereau C, Vassart G, Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129-134.
26. 1 receptor. J Neurosci 17:5327-5333.
27. Gomez del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M (2002) De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 363:183-188.
28. 2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071:10-23.
29. 2 receptor. Eur J Pharmacol 401:17-25.
30. Gudermann T, Schoneberg T, Schultz G (1997) Functional and structural complexity of signal transduction via G protein-coupled receptors. Annu Rev Neurosci 20:399-427.
31. Guzman M, Galve-Roperh I, Sanchez C (2001) Ceramide: A new second messenger of cannabinoid action. Trends Pharmacol Sci 22:19-22.
32. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
33. 2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp Cell Res 312:2121-2131.
34. Howlett AC (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol Pharm 27:429-436.
35. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
36. Howlett AC, Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2- Arachidonoylglycerol. Chem Phys Lipids 108:53-70.
37. 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100:10529-10533.
38. 1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028.
39. Iversen L, Chapman V (2002) Cannabinoids: A real prospect for pain relief. Curr Opin Pharmacol 2:50-55.
40. Jorda MA, Verbakel SE, Valk PJ, Vankan-Berkhoudt YV, Maccarrone M, Finazzi-Agro A, Lowenberg B, Delwel R (2002) Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99:2786-2793.
41. Kaminski NE, Koh WS, Yang KH, Lee M, Kessler FK (1994) Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G protein-coupled mechanism. Biochem Pharmacol 48:1899-1908.
42. Kaplan BL, Rockwell CE, Kaminski NE (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306:1077-1085.
43. Kenakin T (2001) Inverse, protean, and ligand-selective agonism: Matters of receptor conformation. FASEB J 15:598-611.
44. Kenakin T (2002) Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42:349-379.
45. Kishimoto S, Gokoh M, Oka S, Muramatsu M, Kajiwara T, Waku K, Sugiura T (2003) 2- Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J Biol Chem 278:24469-24475.
46. Klein T, Newton C, Larsen K, Lu L, Perkins I, Liang N, Friedman H (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486-496.
47. Kobayashi Y, Arai S, Waku K, Sugiura T (2001) Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J Biochem 129:665-669.
48. Lunn CA, Fine JS, Rojas-Triana A, Jackson JV, Fan X, Kung TT, Gonsiorek W, Schwarz MA, Lavey B, Kozlowski JA, Narula SK, Lundell DJ, Hipkin RW, Bober LA (2006) A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo. J Pharmacol Exp Ther 316:780-788.
49. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
50. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
51. 2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis. Eur J Pharmacol 542:179-183.
52. Maneuf YP, Brotchie JM (1997) Paradoxical action of the cannabinoid WIN 55, 212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br J Pharmacol 120:1397-1398.
53. 2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95:437-445.
54. Matsuda L, Lolait S, Brownstein M, Young A, Bonner T (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
55. McAllister SD, Griffin G, Satin LS, Abood ME (1999) Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther 291:618-626.
56. Molina-Holgado E, Vela JM, Arevalo-Martin A, Almazan G, Molina-Holgado F, Borrell J, Guaza C (2002) Cannabinoids promote oligodendrocyte progenitor survival: Involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 22:9742-9753.
57. Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ, Gibson RM (2005) Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/Akt signaling. Mol Cell Neurosci 28:189-194.
58. 2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. J Neuroimmunol 181:82-92.
59. Munro S, Thomas K, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
60. Oka S, Ikeda S, Kishimoto S, Gokoh M, Yanagimoto S, Waku K, Sugiura T (2004) 2- Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 76:1002-1009.
61. 2 receptors in brain. Ann N Y Acad Sci 1074:514-536.
62. Prather PL (2004) Inverse agonists: Tools to reveal ligand-specific conformations of G proteincoupled receptors. Sci STKE 2004:1.
63. 1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23:2453-2458.
64. Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904-1913.
65. 1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284:345-353.
66. Rayman N, Lam KH, Laman JD, Simons PJ, Lowenberg B, Sonneveld P, Delwel R (2004) Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status. J Immunol 172:2111-2117.
67. 2 cannabinoid receptor. Cancer Res 61:5784-5789.
68. 2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell Signal 15:851-859.
69. 2 cannabinoid receptors mediate antinoception in neuropathic pain in the rat. Pain 109:124-131.
70. 2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307:132-136.
71. 2 cannabinoid receptors. J Pharmacol Exp Ther 314:868-875.
72. 2 receptors. J Pharmacol Exp Ther 315:828-838.
73. 2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 101:87-98.
74. 1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15:91-119.
75. Slipetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M, Metters KM (1995) Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharm 48:352-361.
76. 1 cannabinoid receptor expression in brain regions associated with zebra finch song control. Brain Res 857:151-157.
77. Soderstrom K, Leid M, Moore FL, Murray TF (2000) Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. J Neurochem 75:413-423.
78. 2. Mol Pharm 56:834-840.
79. Strange PG (2002) Mechanisms of inverse agonism at G protein-coupled receptors. Trends Pharmacol Sci 23:89-95.
80. 2+ transient in NG108-15 cells. J Biochem 122:890-895.
81. 2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 275:605-612.
82. 2): evidence for subtype specificity. Mol Pharm 55:605-613.
83. 1 selectivity. Receptor modeling and automated docking analysis. J Med Chem 49:984-994.
84. 2 receptors in the IgEmediated triphasic cutaneous reaction in mice. Life Sci 80:414-419.
85. Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Lowenberg B, Delwel R (1997) The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol 71:6796-6804.
86. 2 receptors. Science 310:329-332.
87. 1 cannabinoid receptor can sequester G proteins, making them unavailable to couple to other receptors. J Neurosci 19:9271-9280.
88. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:1398-1405.
89. Wiens BL, Nelson CS, Neve KA (1998) Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonistspecific active conformations. Mol Pharm 54:435-444.
90. Yamaguchi F, Macrae AD, Brenner S (1996) Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 35:603-605.